[Coomb's-positive hemolytic anemia and tuberculosis in Kaposi's sarcoma treated with interferon].
Immune hemolytic anemia and reactivated tuberculosis developed in a patient treated with alpha-interferon for Kaposi's sarcoma and splenic non-Hodgkin's lymphoma. The hemolytic process stopped on cessation of interferon and initiation of corticosteroid therapy, and the Coomb's test became negative. The possibility of reactivation of tuberculosis by interferon is discussed.
Yermiahu
T
T
Hematology Unit, Soroka Medical Center, Beer Sheba.
Benharroch
D
D
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology*; D003298:Coombs Test; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D012008:Recurrence; D012514:Sarcoma, Kaposi / Q000628:therapy*; D013160:Splenic Neoplasms / Q000628:therapy; D014376:Tuberculosis / Q000150:complications*
D016898:Interferon-alpha